News

The authorization of DermaSensor marks a milestone in AI-enabled devices, highlighting opportunities and challenges in their integration into clinical practice.

Perceived stress, however, did not exhibit any correlations with psycho- and skin physiological parameters.

Individuals in Uyo, Nigeria, with albinism are at great risk of developing photodermatoses due to a lack of photoprotection and awareness of photoprotective behaviors.

Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.

From a financial perspective, the change from resident to attending dermatologist may be profound.

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, examines the most popular active ingredients in redness-reducing formulations.

In one study, less than 5% of images from a HAM10000 database came from patients with darker skin types.

Sara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.

Cutaneous and advanced stage melanomas present significant challenges during pregnancy, according to the posters.

A recent review found that disparities and barriers, such as income, age, and location, can impede patient access to necessary care.

Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.

Dermatologic emergency units are increasingly overwhelmed by rising patient volumes and reduced resources, but store-and-forward teledermatology offers an effective alternative.

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.

Keep up with the latest headlines in dermatology from the past week, including high wait times to access dermatologic care in Quebec, the rise of digital dermatology, and more.

In case you missed it, this week had news about the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, the FDA-approved expanded use of tirbanibulin for actinic keratosis, FDA and EMA support of continuing MoonLake's phase 3 trial of sonelokimab for PsA, and more.

The program’s creator, Hubert Greenway, MD, has personally trained each of the fellowship’s 68 physicians in Mohs surgery.

Weekend treatment with cyclosporine may be beneficial for patients with moderate to severe psoriasis, according to a new study.

The organizations called for skin health to be considered a global public health priority in a recent side meeting at the World Health Assembly.

Researchers compared the examination's content outline with data on skin diseases in a recent study.

Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.

Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.

Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.

Review our coverage and expert interviews from the recent Society of Dermatology Physician Assistants' annual summer meeting.

A recent study found that AD not only affects mental health and QoL, but women’s sexual health and gestational desires as well.

Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.

VYNE Therapeutics Inc. shared that top-line data from the trial is expected in the second half of 2024.

Today, June 13, is the 10th annual International Albinism Awareness Day.